Healthcare · Industry
Drug Manufacturers - General - List & Prices (21 stocks)
All 21 Drug Manufacturers - General stocks listed, ranked by market capitalization — 1 page(s), 50 per page.
What Are the Leading Drug Manufacturers - General Stocks?
Prices: Sep 4, 2026 closeThere are 21 publicly traded Drug Manufacturers - General stocks. The largest by market capitalization are LLY, JNJ, ABBV, MRK, NVS, AZN, AMGN, NVO, GILD, PFE.
| Company | Ticker | Price | Mkt cap | P/E | Div yield |
|---|---|---|---|---|---|
| Eli Lilly and Company | LLY | $1,149.36 | $1.02T | 38.6 | 0.60% |
| Johnson & Johnson | JNJ | $275.23 | $663.28B | 32.0 | 1.93% |
| AbbVie Inc. | ABBV | $256.46 | $453.19B | 73.5 | 2.70% |
| Merck & Co., Inc. | MRK | $150.33 | $370.89B | 122.2 | 2.23% |
| Novartis AG | NVS | $159.99 | $304.10B | 24.6 | 2.91% |
| AstraZeneca PLC | AZN | $162.70 | $252.33B | 24.7 | 1.96% |
| Amgen Inc. | AMGN | $437.23 | $236.38B | 27.6 | 2.27% |
| Novo Nordisk A/S | NVO | $46.60 | $206.02B | 11.7 | 3.78% |
| Gilead Sciences, Inc. | GILD | $151.00 | $187.23B | 2.17% | |
| Pfizer Inc. | PFE | $28.45 | $162.16B | 37.9 | 5.97% |
| Bristol-Myers Squibb Company | BMY | $66.82 | $136.49B | 15.0 | 3.77% |
| Sanofi | SNY | $44.24 | $106.01B | 23.5 | 5.46% |
| GSK plc | GSK | $49.89 | $99.92B | 15.7 | 3.57% |
| Biogen Inc. | BIIB | $220.83 | $32.63B | 39.9 | — |
| Grifols, S.A. | GRFS | $7.80 | $5.31B | 10.3 | 3.58% |
| Organon & Co. | OGN | $13.78 | $3.62B | 17.7 | 0.58% |
| Amarin Corporation plc | AMRN | $13.63 | $287.90M | — | |
| Nasus Pharma Ltd. | NSRX | $3.74 | $43.75M | — | |
| Scilex Holding Company | SCLX | $5.42 | $38.09M | — | |
| MIRA Pharmaceuticals, Inc. | MIRA | $0.76 | $32.10M | — | |
| Medicus Pharma Ltd. | MDCX | $0.17 | $10.87M | — |
Eli Lilly and Company
Healthcare / Drug Manufacturers - General
- Market Cap
- $1.02T
- P/E
- 38.6
- Dividend Yield
- 0.60%
Johnson & Johnson
Healthcare / Drug Manufacturers - General
- Market Cap
- $663.28B
- P/E
- 32.0
- Dividend Yield
- 1.93%
AbbVie Inc.
Healthcare / Drug Manufacturers - General
- Market Cap
- $453.19B
- P/E
- 73.5
- Dividend Yield
- 2.70%
Merck & Co., Inc.
Healthcare / Drug Manufacturers - General
- Market Cap
- $370.89B
- P/E
- 122.2
- Dividend Yield
- 2.23%
Novartis AG
Healthcare / Drug Manufacturers - General
- Market Cap
- $304.10B
- P/E
- 24.6
- Dividend Yield
- 2.91%
AstraZeneca PLC
Healthcare / Drug Manufacturers - General
- Market Cap
- $252.33B
- P/E
- 24.7
- Dividend Yield
- 1.96%
Amgen Inc.
Healthcare / Drug Manufacturers - General
- Market Cap
- $236.38B
- P/E
- 27.6
- Dividend Yield
- 2.27%
Novo Nordisk A/S
Healthcare / Drug Manufacturers - General
- Market Cap
- $206.02B
- P/E
- 11.7
- Dividend Yield
- 3.78%
Gilead Sciences, Inc.
Healthcare / Drug Manufacturers - General
- Market Cap
- $187.23B
- P/E
- unprofitable
- Dividend Yield
- 2.17%
Pfizer Inc.
Healthcare / Drug Manufacturers - General
- Market Cap
- $162.16B
- P/E
- 37.9
- Dividend Yield
- 5.97%
Bristol-Myers Squibb Company
Healthcare / Drug Manufacturers - General
- Market Cap
- $136.49B
- P/E
- 15.0
- Dividend Yield
- 3.77%
Sanofi
Healthcare / Drug Manufacturers - General
- Market Cap
- $106.01B
- P/E
- 23.5
- Dividend Yield
- 5.46%
GSK plc
Healthcare / Drug Manufacturers - General
- Market Cap
- $99.92B
- P/E
- 15.7
- Dividend Yield
- 3.57%
Biogen Inc.
Healthcare / Drug Manufacturers - General
- Market Cap
- $32.63B
- P/E
- 39.9
Grifols, S.A.
Healthcare / Drug Manufacturers - General
- Market Cap
- $5.31B
- P/E
- 10.3
- Dividend Yield
- 3.58%
Organon & Co.
Healthcare / Drug Manufacturers - General
- Market Cap
- $3.62B
- P/E
- 17.7
- Dividend Yield
- 0.58%
Amarin Corporation plc
Healthcare / Drug Manufacturers - General
- Market Cap
- $287.90M
- P/E
- unprofitable
Nasus Pharma Ltd.
Healthcare / Drug Manufacturers - General
- Market Cap
- $43.75M
- P/E
- unprofitable
Scilex Holding Company
Healthcare / Drug Manufacturers - General
- Market Cap
- $38.09M
- P/E
- unprofitable
MIRA Pharmaceuticals, Inc.
Healthcare / Drug Manufacturers - General
- Market Cap
- $32.10M
- P/E
- unprofitable
Medicus Pharma Ltd.
Healthcare / Drug Manufacturers - General
- Market Cap
- $10.87M
- P/E
- unprofitable
Showing 1–21 of 21 · ranked by market capitalization
Where the trailing year was a loss, P/E appears as “unprofitable”; a dash is missing data. Ranked by market capitalization. Prices are the most recent daily close.
Which Drug Manufacturers - General Stocks Are Reasonably Valued?
Prices: Sep 4, 2026 closeAmong the 21 largest Drug Manufacturers - General companies, Grifols, S.A. (GRFS) trades at the lowest trailing P/E ratio, 10.3. The industry average is 34.3.
| Company | Ticker | Price | Mkt cap | P/E | Div yield |
|---|---|---|---|---|---|
| Grifols, S.A. | GRFS | $7.80 | $5.31B | 10.3 | 3.58% |
| Novo Nordisk A/S | NVO | $46.60 | $206.02B | 11.7 | 3.78% |
| Bristol-Myers Squibb Company | BMY | $66.82 | $136.49B | 15.0 | 3.77% |
| GSK plc | GSK | $49.89 | $99.92B | 15.7 | 3.57% |
| Organon & Co. | OGN | $13.78 | $3.62B | 17.7 | 0.58% |
Ranked by trailing twelve-month P/E, lowest first. Companies that report no P/E are not listed. Rankings cover the 21 largest Drug Manufacturers - General companies by market capitalization.
Which Drug Manufacturers - General Stocks Pay the Highest Dividends?
Prices: Sep 4, 2026 close15 of the 21 largest Drug Manufacturers - General companies pay a dividend. Pfizer Inc. (PFE) has the highest yield at 5.97%.
| Company | Ticker | Price | Mkt cap | P/E | Div yield |
|---|---|---|---|---|---|
| Pfizer Inc. | PFE | $28.45 | $162.16B | 37.9 | 5.97% |
| Sanofi | SNY | $44.24 | $106.01B | 23.5 | 5.46% |
| Novo Nordisk A/S | NVO | $46.60 | $206.02B | 11.7 | 3.78% |
| Bristol-Myers Squibb Company | BMY | $66.82 | $136.49B | 15.0 | 3.77% |
| Grifols, S.A. | GRFS | $7.80 | $5.31B | 10.3 | 3.58% |
Ranked by trailing dividend yield, highest first. Companies that pay no dividend are not listed. Rankings cover the 21 largest Drug Manufacturers - General companies by market capitalization.
Key facts
As of September 4, 2026, 21 Drug Manufacturers - General stocks are listed on NYSE/NASDAQ and TSX.
The largest by market capitalization is Eli Lilly and Company (LLY) at $1.02T.
The median P/E across the Drug Manufacturers - General industry is 24.7.
Drug Manufacturers - General Industry Overview
From the data · Sep 4, 2026The Drug Manufacturers - General industry, part of the Healthcare sector, includes 21 publicly traded companies with a combined market capitalization of $4.24T. The industry is led by Eli Lilly and Company (LLY), Johnson & Johnson (JNJ), AbbVie Inc. (ABBV).
Among the 21 listed Drug Manufacturers - General companies, market capitalizations range from $1.02T (Eli Lilly and Company) down to $304.10B (Novartis AG), highlighting the wide size disparity across the industry. The average market cap across the industry is $202.14B, reflecting a mix of established large-cap players and smaller growth-oriented companies.
Drug Manufacturers - General Industry Valuation
The Drug Manufacturers - General industry currently trades at an average price-to-earnings (P/E) ratio of 34.3. This elevated multiple indicates that investors are pricing in strong future earnings growth across Drug Manufacturers - General companies.
Drug Manufacturers - General Dividend Profile
15 out of 21 Drug Manufacturers - General companies (71%) currently pay dividends to shareholders. The average dividend yield across dividend-paying Drug Manufacturers - General stocks is 2.90%. The high proportion of dividend payers suggests Drug Manufacturers - General is a mature, cash-generating industry that rewards income-focused investors.
Frequently Asked Questions
What are the leading Drug Manufacturers - General stocks?
The largest Drug Manufacturers - General stocks by market capitalization are Eli Lilly and Company (LLY), Johnson & Johnson (JNJ), AbbVie Inc. (ABBV), Merck & Co., Inc. (MRK), Novartis AG (NVS). All 21 companies are ranked by market cap on this page.
Where can I find a complete list of Drug Manufacturers - General stocks?
This page is the complete list: 21 Drug Manufacturers - General companies across 1 page(s), 50 per page, ranked by market capitalization — including LLY, JNJ, ABBV, MRK, NVS.
How many Drug Manufacturers - General stocks are there?
There are 21 publicly traded Drug Manufacturers - General companies listed on major US exchanges, ranging from Eli Lilly and Company (LLY) to Novartis AG (NVS) by market capitalization. This directory spans 1 pages, with all companies sorted by market cap for easy comparison.
Which Drug Manufacturers - General stocks are reasonably valued?
Among the 21 largest Drug Manufacturers - General companies, Grifols, S.A. (GRFS) carries the lowest trailing P/E at 10.3, against an industry average of 34.3.
Which Drug Manufacturers - General stocks have the highest dividend yield?
15 of the 21 Drug Manufacturers - General companies (71%) pay a dividend, with an average yield of 2.90% among payers. The highest yield among the 21 largest is Pfizer Inc. (PFE) at 5.97%.
Explore Drug Manufacturers - General Stocks on StockVS
StockVS provides detailed fundamental data, historical price charts, and side-by-side comparisons for all 21 Drug Manufacturers - General companies. Browse individual stock pages for in-depth analysis, or use our comparison tool to evaluate two Drug Manufacturers - General stocks head to head. All data is updated regularly to reflect the latest available financials.